The process of diagnosis uses data collection and complex analysis to determine a patient’s health and course of treatment. Accurate diagnosis is the most critical aspect of health care.

Within the cord blood industry, there was a robust growth period during the mid-to-late 2000s. However, over the past several years, the market has matured and consolidated. While strong industry growth has continued within North Asia (particularly within China, Hong Kong, and Taiwan) and Southeast Asia (led by India and Malaysia), growth within the North American and European markets has not been as robust. 

Cell-based research helps in the evaluation of diagnostic and therapeutic applications of various types of cells in the management of chronic and infectious diseases.

The availability of government support for promoting and supporting cell-based research activities, such as single-cell analysis and stem cell research, is driving research into the application and end-user industries for cell analysis.

Medical device companies produce a wide variety of products such as wheelchairs, defibrillators, pacemakers, stents, and infusion pumps.

The medical device industry is highly regulated, and companies must invest in constant research and development in order to maintain a competitive edge.

The in vitro diagnostics (IVD) instruments, kits, reagents, and related supplies market is projected to grow to $74 billion by 2022.

Diagnostics providers are actively expanding into markets in developing countries, where there is a rising demand for quality healthcare services. However, stable in vitro diagnostics market growth is also expected in developed countries.

Life sciences tends to be a source of competitive and investor interest, because of its potential role in fighting disease and increasing human health. We asked one of our publishers, Kalorama Information, to talk about its recently published market studies. The publisher noted the following areas of health care.

The American Association for Clinical Chemistry (AACC) is about to host its 69th Annual Scientific Meeting & Clinical Lab Expo, which will take place from July 31 through August 4.

According to the AACC website, the expo showcases a variety of cutting-edge technology with more than 200 new product introductions each year. With so much happening in the field, what should attendees expect to see?

Clinical laboratories are a critical component of health care. Approximately 80% of physicians’ diagnoses are a result of laboratory tests, according to Kalorama Information, a healthcare market research firm.

Common routine tests include cholesterol level tests, HIV tests, pap tests, pregnancy tests, and substance abuse tests. Clinical lab testing is also used to monitor diseases and drug treatments. Specialty testing, which is often more costly, may include genetics, immunology, oncology, endocrinology, and other segments.

Kalorama Information provides life sciences industry research for leading drug, diagnostic, and medical device companies. Kalorama uses expert healthcare analysts who are highly knowledgeable and adept at discovering current trends. This publisher is regularly cited as a credible source by major news outlets such as The Wall Street Journal, Associated Press, The New York Times, Genetic Engineering News, Contract Pharma, and Becker’s Hospital Review.

This year, Kalorama Information has released a number of new market research reports on key diagnostics and medical device industries. Three major reports are profiled below.

As patients take a more proactive role in their own health care, direct-to-consumer (DTC) laboratory testing is becoming increasingly popular. DTC genetic tests allow consumers to access information about their genetics without necessarily involving healthcare professionals in the process. 

A number of established and emerging companies are competing in this growing market. Kalorama Information, a healthcare market research firm, recently profiled a variety of prominent market participants in its report The Market for Direct-to-Consumer Genetic Testing and Routine Laboratory Testing. This blog post highlights 9 of these companies that are among the leaders in the industry.